Login required to access links in this section
The Cancer program at TRI brings together scientists and clinicians with a shared interest and expertise in cancers such as squamous cell carcinoma, breast cancer, prostate cancer, skin cancer, melanoma and metastatic disease.
Researchers use techniques that “mimic” human cancer pathogenesis to examine the establishment and progression of disease. This allows basic research investigations to be translated into clinical trials to address significant clinical questions, and potentially trial new therapies or diagnostics. Specialised cancer groups such as IHBI Cancer program led by Professor Judith Clements aims to understand more clearly the molecular and cellular basis for the development, progression, and metastasis of several cancers. This includes other hormone dependent cancers such as those of the reproductive and urogenital organs, breast, ovary, endometrium, and kidney, as well as skins, lung, blood, and head and neck cancers. melanoma and lung cancer.